Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL546996 | 0.91 | PYGM (0.57) | TK2PYGM | |
| SCHEMBL14853756 | 0.91 | PYGM (0.57) | TK2PYGM | |
| SCHEMBL14930959 | 0.91 | PYGM (0.57) | TK2PYGM | |
| SCHEMBL14929088 | 0.91 | PYGM (0.57) | TK2PYGM | |
| SCHEMBL14842287 | 0.91 | PYGM (0.57) | TK2PYGM | |
| SCHEMBL26370054 | 0.88 | PYGM (0.47) | TK2PYGM | |
| SCHEMBL442314 | 0.87 | PYGM (0.53) | TK2PYGM | |
| SCHEMBL31155735 | 0.86 | P2RY6 (0.53) | TK2PYGM | |
| SCHEMBL19614649 | 0.84 | TK2 (0.53) | TK2PYGM | |
| SCHEMBL2027440 | 0.84 | TK2 (0.53) | TK2PYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025052108-A2 | RNA MOLECULE | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-03-13 | — | — | WO | disclosed |
| WO-2025038850-A1 | LIPID NANOPARTICLES AND METHODS FOR SENSITIZING RESPONSE TO AN IMMUNOTHERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-20 | — | — | WO | disclosed |
| EP-4486909-A2 | RNA MOLECULE | Imperial College Innovations Limited (GB) | 2025-01-08 | — | — | EP | disclosed |
| EP-4240396-A1 | USE OF IFN-LAMBDA MRNA FOR TREATING VIRAL INFECTIONS | Ethris GmbH (DE) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023166314-A2 | RNA MOLECULE | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-09-07 | — | — | WO | disclosed |
| WO-2022096582-A1 | USE OF IFN-LAMBDA MRNA FOR TREATING VIRAL INFECTIONS | ETHRIS GMBH (DE) | 2022-05-12 | — | — | WO | disclosed |